OS Therapies Reports Pricing Of Its IPO Of 1.60M Shares At $4.00 Per Share, Raising Gross Proceeds Of $6.4M
Portfolio Pulse from Benzinga Newsdesk
OS Therapies has priced its IPO at $4.00 per share, raising $6.4M. The funds will be used for clinical development of OST-HER2 and OST-tADC, new product discovery, and general corporate purposes. Trading on the NYSE American under the symbol 'OSTX' begins August 1, 2024.
July 31, 2024 | 10:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OS Therapies has priced its IPO at $4.00 per share, raising $6.4M. The funds will be used for clinical development of OST-HER2 and OST-tADC, new product discovery, and general corporate purposes. Trading on the NYSE American under the symbol 'OSTX' begins August 1, 2024.
The IPO pricing and the start of trading on the NYSE American are significant events for OS Therapies. The raised funds will support the company's clinical development and new product discovery, which are positive indicators for future growth. The stock price is likely to see an initial uptick as it begins trading.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100